Status:
COMPLETED
Estimation of the MCID for Patients With Knee Osteoarthritis
Lead Sponsor:
Istanbul University
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
50-75 years
Phase:
NA
Brief Summary
Background: The effect of exercise on knee osteoarthritis (OA) is often evaluated with patient-reported scales. The Minimal Clinically Important Difference (MCID) values of these scales are needed to ...
Eligibility Criteria
Inclusion
- To be diagnosed with knee OA according to the criteria of the American Society of Rheumatology (ACR) (Diagnosis of primary knee OA)
- Stage 2 or 3 according to Kellgren Lawrence radiological staging criteria
- Participants with age between 50 and 70 years old
- Being able to walk without using an assistive device
- Having a body mass index of less than 30 kg/m²
- Pain severity is between 3 and 7 according to the Numerical Pain Rating Scale
Exclusion
- Patients who received physical therapy or intra-articular injections in the last 6 months
- Receiving an indication for surgery
- Have severe hearing, vision and speech impairment
- Having serious systemic and cardiovascular diseases that interfere with exercise
- Having a lower extremity deformity
- Patients with acute inflammation of the knee
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2023
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06034665
Start Date
February 1 2022
End Date
December 5 2023
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istinye University Physiotherapy and Rehabilitation Application and Research Center
Istanbul, Turkey (Türkiye)